Material Agreements

AMERICAN AIRLINES, INC. amended 2014 Eleventh Amendment with Citibank, N.A., as administrative agent, and the lenders valued at incremental revolving credit commitments of $1,295.8 million and new letter of credit commitments of (effective 2026-03-05).

“On March 5, 2026, the Company and AAG entered into the Eleventh Amendment to Amended and Restated Credit and Guaranty Agreement (the “2014 Eleventh Amendment”), amending the Amended and Restated Credit and Guaranty Agreement, dated as of April 20, 2015 (as amended or amended and restated prior to the 2014 Eleventh Amendment, the “Prior 2014 Credit Agreement” and, as amended by the 2014 Eleventh Amendment, the “2014 Credit Agreement”), by and among the Company, AAG, the lenders party thereto, the issuing lenders party thereto and Citibank, N.A., as administrative agent.”

HUMANA INC entered into First Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-09).

“as supplemented by a first supplemental indenture, dated as of March 9, 2026, by and between the Company and the Trustee relating to the Subordinated Notes (the “First Supplemental Indenture””

HUMANA INC entered into Original Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-05).

“The Subordinated Notes were issued under an amended and restated indenture dated as of March 5, 2026, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”) (the “Original Indenture")”

HUMANA INC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC valued at $1.0 billion (effective 2026-03-05).

“On March 5, 2026, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $1.0 billion aggregate principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056”

MARZETTI CO amended First Amendment to Credit Agreement with The Huntington National Bank, Bank of America, N.A., JPMorgan Chase Bank, N.A., and the other lenders named therein valued at $200 million term loan (effective 2026-03-04).

“The Amendment provides for an increase to the revolving loan from $150 million to $200 million, and for an additional $200 million term loan”

SELECTIS HEALTH, INC. entered into Operations Transfer Agreement with Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC (effective 2026-03-05).

“Concurrently with the execution of the PSA, the Company caused the Existing Operators to execute an Operations Transfer Agreement (“ OTA ”) with two newly formed entities affiliated with the Purchasers, Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC, each a Georgia limited liability company (each a “ New Operator ”)”

SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC valued at $15,700,000.00 (effective 2026-03-05).

“Effective on March 5, 2026, Selectis Health, Inc., a Utah corporation (the “ Company ”) caused two of the Company’s wholly-owned subsidiaries Global Abbeville Property, LLC and Dodge NH, LLC , each a Georgia limited liability company (each a “ Seller ”) to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with two newly formed entities: Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC, each a Georgia limited liability company (each a “ Purchaser ”)”

Essential Utilities, Inc. entered into Tenth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $500,000,000 principal amount (effective 2026-03-09).

“On March 9, 2026, Essential Utilities, Inc. (the “Company”) issued $500,000,000 principal amount of its 5.125% Senior Notes due 2036 (the “Notes”).”

SM Energy Co entered into Indenture for 6.625% Senior Notes due 2034 with U.S. Bank Trust Company, National Association valued at $1,000,000,000 aggregate principal amount of 6.625% Senior Notes due 2034; maturity April 15, 2034; (effective 2026-03-09).

“On March 9, 2026, the Company entered into the Indenture relating to the Notes (the “ Indenture ”), with the guarantors party thereto and U.S. Bank Trust Company, National Association, a national banking association, as trustee (the “ Trustee ”), governing the Notes.”

SM Energy Co entered into Purchase Agreement for 6.625% Senior Notes due 2034 with BofA Securities, Inc. valued at $1,000,000,000 aggregate principal amount of 6.625% Senior Notes due 2034 (effective 2026-03-04).

“On March 9, 2026, SM Energy Company (the “ Company ”) issued and sold $1.0 billion in aggregate principal amount of the Company’s 6.625% Senior Notes due 2034 (the “ Notes ”), pursuant to a Purchase Agreement, dated March 4, 2026, among the Company, the guarantors party thereto (the “ Subsidiary Guarantors ”) and BofA Securities, Inc., acting as representative of the several initial purchasers named therein (the “ Initial Purchasers ”).”

SL GREEN REALTY CORP amended Thirty-Second Amendment with SL Green Operating Partnership, L.P. (effective 2026-03-04).

“On March 4, 2026, SL Green Realty Corp. (the “Company”), as the general partner of SL Green Operating Partnership, L.P. (the “Operating Partnership”), entered into a thirty-second amendment (the “Thirty-Second Amendment”) to the Operating Partnership’s First Amended and Restated Agreement of Limited Partnership, dated August 20, 1997”

Modular Medical, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at cash fee equal to 7% of the gross proceeds (effective 2026-03-03).

“On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses. Pursuant to the Placement Agency Agreement, the Company paid the Placement Agent a cash fee equal to 7% of the gross proceeds received from the Offering and reimbursed the Placement Agent for its expe”

Modular Medical, Inc. entered into Securities Purchase Agreements with multiple investors valued at gross proceeds of approximately $12 million (effective 2026-03-03).

“On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses.”

DYADIC INTERNATIONAL INC entered into At-The-Market Issuance Sales Agreement with Craig-Hallum Capital Group LLC valued at up to $4,237,818 (effective 2026-03-06).

“On March 6, 2026, Dyadic International, Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC, as sales agent (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time, at its option, shares of the Company’s common stock having an aggregate offering price of up to $4,237,818”

Amphastar Pharmaceuticals, Inc. amended Contract Research Amendment with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. valued at approximately $0.6 million (effective 2026-03-03).

“On March 3, 2026 (the “Effective Date”), Amphastar Pharmaceuticals, Inc (“Amphastar” or, the “Company”) and Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (“Hanxin”) entered into an amendment (the “Contract Research Amendment”) to the Contract Research Agreement (the “Contract Research Agreement”), originally entered into on September 15, 2025, as previously reported by the Company on a Current Report on Form 8-K filed on September 18, 2025.”

Amphastar Pharmaceuticals, Inc. entered into Supply Agreement with Nanjing Letop Biotechnology Co., Ltd. (effective 2026-03-03).

“On March 3, 2026, (the “Effective Date”), Amphastar Nanjing Pharmaceuticals, Inc. (“ANP”), the Chinese subsidiary of Amphastar Pharmaceuticals, Inc. (“Amphastar” or, the “Company”), entered into a supply agreement (the “Supply Agreement”) with Nanjing Letop Biotechnology Co., Ltd. (“Letop”).”

Waste Connections, Inc. entered into Underwriting Agreement with BofA Securities, Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC and Truist Securities, Inc., as representatives of the several underwriters named therein valued at $600 million aggregate principal amount (effective 2026-03-05).

“On March 5, 2026, Waste Connections, Inc. (“Waste Connections” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC and Truist Securities, Inc., as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering (the “Offering”) by Waste Connections of $600 million aggregate principal amount of its 4.800% Senior Notes due 2036 (the “Notes”).”

Duke Energy CORP entered into Equity Distribution Agreement with multiple financial institutions acting as sales agents and forward purchasers valued at up to an aggregate sales price of $6,000,000,000 (effective 2026-03-06).

“nergy Corporation (the “Company”) entered into an Equity Distribution Agreement dated March 6, 2026 (the “Equity Distribution Agreement”) with Barclays Capital Inc., BMO Capital Markets Corp., BNY Mellon Capital Markets, LLC, BofA Securities, Inc.,”

AMC ENTERTAINMENT HOLDINGS, INC. entered into Commitment Letter with Deutsche Bank AG New York Branch valued at $425,000,000 (effective 2026-03-06).

“On March 6, 2026, AMC Entertainment Holdings, Inc. (the “Company,” or “AMC”), together with its wholly-owned subsidiary Odeon Finco PLC (“Odeon”), entered into a commitment letter (the “Commitment Letter”) with Deutsche Bank AG New York Branch (the “Lender”) providing for a new senior secured credit facility of Odeon in an aggregate principal amount of up to $425,000,000 (the “Odeon Credit Facility”).”

HIGH WIRE NETWORKS, INC. entered into Global Settlement and Mutual Release Agreement with Thoth Aerospace Inc., Dennis O’Leary, Mark W. Porter valued at Aggregate settlement amount of $150,000 payable in installments equal to 5% of gross proceeds from e (effective 2026-03-03).

“On March 3, 2026, in connection with the transactions contemplated by the Agreement, the Company, Thoth, the Selling Shareholder, and Mark W. Porter entered into a Global Settlement and Mutual Release Agreement (the “Settlement Agreement”).”

HIGH WIRE NETWORKS, INC. entered into Securities Exchange Agreement with Thoth Aerospace Inc. valued at Issuance of 16,597,353 shares of common stock (80% of fully diluted shares) in exchange for all Thot (effective 2026-03-03).

“On March 3, 2026, High Wire Networks, Inc., a Nevada corporation (the “ Company ”), entered into a Securities Exchange Agreement (the “ Agreement ”) with Thoth Aerospace Inc., a New York corporation (“ Thoth ”), Dennis O’Leary, the sole shareholder of Thoth (the “ Selling Shareholder ”), and Mark W. Porter, the Company’s sole officer and director and a holder of shares of the Company’s Series B Preferred Stock.”

Spirit Aviation Holdings, Inc. entered into Consent and Waiver with certain beneficial and record holders of the Company's common stock and warrants (effective 2026-03-05).

“On March 5, 2026, Spirit Aviation Holdings, Inc. (the “Company”) and certain beneficial and record holders (the “Holders”) of the shares of common stock of the Company (the “Common Stock”) and the warrants of the Company entered into a consent and waiver (the “Consent and Waiver”) to that certain Registration Rights Agreement, dated as of March 12, 2025 (the “Registration Rights Agreement”).”

MacKenzie Realty Capital, Inc. entered into Note Purchase Agreement with Streeterville Capital, LLC valued at $1,095,000 (effective 2026-03-06).

“On March 6, 2026, MacKenzie Realty Capital, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) by and between the Company and Streeterville Capital, LLC (the “Investor”).”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreements with Streeterville Capital, LLC (effective 2026-02-25).

“reviously disclosed, on June 26, 2025, the Company entered into a note purchase agreement with Streeterville Capital, LLC (“Streeterville”) pursuant to which the Company issued and sold to Streeterville a secured promissory note in the original principal amount of $5,470,000.”

Medalist Diversified, Inc. entered into Purchase and Sale Agreement with HPX Goldsboro Ashley Center LLC valued at $16,600,000 (effective 2026-03-05).

“On March 5, 2026, (the “Effective Date”), MDR Ashley Plaza, LLC, a Delaware limited liability company (the “Seller”), entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”), with HPX Goldsboro Ashley Center LLC, a Delaware limited liability company (the “Purchaser”), whereby the Purchaser agreed to acquire (the “Acquisition”) a 156,012 square foot retail property located at 201–221 North Berkeley Boulevard in Goldsboro, North Carolina (the “Ashley Plaza Property”).”

Alzamend Neuro, Inc. entered into At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC valued at up to $3.0 million (effective 2026-03-06).

“On March 6, 2026, Alzamend Neuro, Inc. (the “ Company ”) entered into an At-the-Market Issuance Sales Agreement (the “ Sales Agreement ”) with Ascendiant Capital Markets, LLC, as sales agent (the “ Agent ”) to sell shares of its common stock, par value $0.0001 (the “ Common Stock ”), having an aggregate offering price of up to $3.0 million (the “ Shares ”) from time to time, through an “at the market offering””

CANADIAN PACIFIC KANSAS CITY LTD/CN entered into Eighth Supplemental Indenture with Computershare Trust Company N.A. (effective 2026-03-06).

“The Securities were issued pursuant to an Indenture, dated as of September 11, 2015, by the Company and Computershare Trust Company N.A., as successor to Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by the Eighth Supplemental Indenture, dated as of March 6, 2026 (the “Eighth Supplemental Indenture”), by and among the Company, the Guarantor and the Trustee.”

CANADIAN PACIFIC KANSAS CITY LTD/CN entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Barclays Capital Inc., Citigroup Global Markets Inc. and SMBC Nikko Securities America, Inc. (effective 2026-03-04).

“on March 4, 2026, the Company and the Guarantor entered into an Underwriting Agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, Barclays Capital Inc., Citigroup Global Markets Inc. and SMBC Nikko Securities America, Inc., as representatives of the several Underwriters listed in Schedule 1 thereto.”

Sadot Group Inc. amended First Amendment to Stock Purchase Agreement with Stanley Hills, LLC (effective 2026-03-02).

“On March 2, 2026, Sadot Group Inc. (the "Company") entered into a First Amendment to Stock Purchase Agreement (the "SPA Amendment") with Stanley Hills, LLC (the "Purchaser"), amending the Securities Purchase Agreement dated February 11, 2026 (the "Original SPA"), pursuant to which the Company previously issued and sold 10,000 shares of the Company's Series A Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), to the Purchaser for an aggregate purchase price of $145,244.”

Solid Biosciences Inc. entered into Securities Purchase Agreement with certain institutional accredited investors valued at approximately $240.0 million (effective 2026-03-06).

“On March 6, 2026, Solid Biosciences Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain institutional accredited investors (the “ Investors ”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement an aggregate of 14,973,257 shares of the Company’s common stock, par value $0.001 per share (the “ Shares ”), at a price of $5.61 per share, and, to investors who so choose in lieu of Shares, pre-funded warrants to purchase 27,807,482 shares of the Company’s common stock (the “ Pre-Funded Warrants ”), at a price of $5.609 per Pre-Funded Warrant (the “ Private Placement ”).”

5&2 Studios, Inc. entered into Vendor Advance Agreement with Come and See Foundation, Inc. ("CAS") valued at up to approximately $24.7 million (effective 2026-03-02).

“the Company entered into a Vendor Advance Agreement (the “Vendor Advance Agreement”) with Come and See Foundation, Inc. (“CAS”) on March 2, 2026”

OS Therapies Inc entered into Purchase Agreement with certain accredited investors valued at $2,200,000 aggregate principal amount of Notes and $2,000,000 aggregate gross proceeds (effective 2026-03-04).

“On March 4, 2026, OS Therapies Incorporated (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors (collectively, the "Purchasers"), pursuant to which the Company agreed to issue and sell to the Purchasers, in a private placement (the "Private Placement"), (i) 10.0% original issue discount unsecured convertible promissory notes (the "Notes") and (ii) warrants to purchase shares of the Company's common stock (the "Warrants" and, together with the Notes, the "Securities").”

Velo3D, Inc. amended February 2025 Note Amendment with Thieneman Construction, Inc. (effective 2026-03-04).

“On March 4, 2026, the Company and Thieneman Construction entered into an Amendment to Senior Secured Convertible Promissory Note (the “February 2025 Note Amendment”), which amended certain provisions of the February 2025 Note to, among other things, provide that, subject to the existing terms of the February 2025 Note, accrued and unpaid interest thereon, in addition to the outstanding principal amount, may be convertible into common stock at the holder’s option.”

Velo3D, Inc. amended January 2025 Note Amendment with Arrayed Notes Acquisition Corp. (effective 2026-03-04).

“On March 4, 2026, the Company and Arrayed entered into an Amendment to Senior Secured Convertible Promissory Note (the “January 2025 Note Amendment”), which amended certain provisions of the January 2025 Note to, among other things, provide that, at any time and from time to time, the Holder has the right, at its option, to convert all or any portion of the outstanding principal amount of the January 2025 Note, together with accrued and unpaid interest thereon, into shares of the Company’s common stock, par value $0.00001 per share.”

Nuvve Holding Corp. entered into Aggregation Service Agreement with Oelion AB and OMNIA Group Holdings AG (effective 2026-03-06).

“and (ii) an aggregation service agreement for battery energy storage system (BESS) (the “Aggregation Service Agreement” and together with the Cooperation Agreement and the Managerial Services Agreement, the “Omnia Venture Agreements”).”

Nuvve Holding Corp. entered into Managerial Services Agreement with Oelion AB and OMNIA Group Holdings AG valued at approximately $1,345,389 (effective 2026-03-06).

“Concurrently with entry into the Cooperation Agreement the Company, Oelion and Omnia also entered into (i) a service agreement for engineering and managerial consulting services (the “Managerial Services Agreement”)”

Nuvve Holding Corp. entered into Cooperation Agreement with Oelion AB and OMNIA Group Holdings AG valued at approximately $1,018,165 (effective 2026-03-06).

“On March 6, 2026, Nuvve Holding Corp. (the “Company” or “Nuvve”) entered into a cooperation agreement (the “Cooperation Agreement”) between and among the Company, Oelion AB, a company organized under the laws of Sweden (“Oelion”), and OMNIA Group Holdings AG, a company organized under the laws of Switzerland (“Omnia”).”

Core Scientific, Inc./tx entered into Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at $500.0 million (effective 2026-03-04).

“On March 4, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into a loan facility Credit Agreement (the “Credit Agreement”), by and among the Company, as borrower, the lenders party thereto from time to time (the “Lenders”) and Morgan Stanley Senior Funding, Inc. (“MSSF”), as administrative agent and collateral agent.”

Dave Inc./DE entered into Purchase Agreement with J.P. Morgan Securities LLC, UBS Securities LLC and Evercore Group L.L.C., as representatives of the several initial purchasers valued at $175 million aggregate principal amount (effective 2026-03-04).

“On March 4, 2026, Dave Inc. (the “Company” or “Dave”) entered into a purchase agreement (the “Purchase Agreement”) by and among the Company and J.P. Morgan Securities LLC, UBS Securities LLC and Evercore Group L.L.C., as representatives of the several initial purchasers named therein (collectively, the “Initial Purchasers”), in connection with the Company’s offering of $175 million aggregate principal amount of 0% Convertible Senior Notes due 2031 (the “Notes”)”

indie Semiconductor, Inc. entered into Indenture with U.S. Bank Trust Company, National Association, as trustee (effective 2026-03-06).

“The Notes were issued pursuant to an Indenture, dated March 6, 2026, (the “ Indenture ”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”).”

indie Semiconductor, Inc. entered into Purchase Agreement with Deutsche Bank Securities Inc. and TD Securities (USA) LLC, as representatives of the several initial purchasers valued at $150,000,000 aggregate principal amount (effective 2026-03-03).

“The Notes were sold under a purchase agreement (the “ Purchase Agreement ”), dated as of March 3, 2026, entered into by and among the Company and Deutsche Bank Securities Inc. and TD Securities (USA) LLC, as representatives of the several initial purchasers named therein (collectively the “ Initial Purchasers ”) pursuant to which the Company agreed to sell $150,000,000 aggregate principal amount of 4.00% Convertible Senior Notes due 2031 (the “ Notes ”).”

Solid Power, Inc. amended Amended and Restated Assistance Agreement with United States Department of Energy valued at Amended and restated Assistance Agreement modifying terms and conditions applicable to award (effective 2026-01-01).

“On March 5, 2026, Solid Power Operating, Inc., a wholly owned subsidiary of Solid Power, Inc. (collectively, the “Company,” “Solid Power,” “we,” or “our”), and the United States Department of Energy (the “DOE”) entered into an amended and restated Assistance Agreement (the “Amended Agreement”), with an effective date of January 1, 2026.”

Day One Biopharmaceuticals, Inc. entered into Agreement and Plan of Merger with Servier Pharmaceuticals LLC, Servier Detroit Inc., and Servier S.A.S. (effective 2026-03-06).

“On March 6, 2026, Servier Pharmaceuticals LLC, a Delaware limited liability company (“ Parent ”), Servier Detroit Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), Day One Biopharmaceuticals, Inc., a Delaware corporation (the “ Company ”), and Servier S.A.S., a French société par actions simplifiée , solely as a guarantor (“ Guarantor ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”).”

Perfect Moment Ltd. amended Further Amended and Restated Note with Max Gottschalk (effective 2026-03-06).

“On March 6, 2026, Gottschalk and the Company entered into a further amended and restated promissory note (the “Further Amended and Restated Note”) to amend and restate the Amended and Restated Note.”

Allarity Therapeutics, Inc. entered into Note Purchase Agreement with Streeterville Capital, LLC valued at $20,930,000 aggregate principal (A-1 Note $10,930,000, B Note $10,000,000) (effective 2026-03-02).

“On March 2, 2026, Allarity Therapeutics, Inc., a Delaware corporation (the “ Company ”) entered into a note purchase agreement (the “ Purchase Agreement ”) with Streeterville Capital, LLC, a Utah limited liability company (“ Lender ”), pursuant to which the Company issued and sold to the Lender (i) a promissory note in the original principal amount of $10,930,000 (the “ A-1 Note ,” together with any notes issued pursuant to the Note Exchange (as defined below), the “ A Notes ”) and (ii) a secured promissory note in the original principal amount of $10,000,000 (the “ B Note ,” and together with the A Notes, the “ Notes ”; each individually, a “ Note” ).”

CID Holdco, Inc. entered into Registration Rights with J.J. Astor & Co..

“The Company also entered into a registration rights agreement with the Lender (the “Registration Rights”) that requires the Company to file a resale shelf registration statement registering the resale of up to 100% of the conversion shares issuable upon conversion of the Initial Note and any Additional Notes following an Event of Default (as defined under the Loan Agreement).”

CID Holdco, Inc. entered into Loan Agreement with J.J. Astor & Co. valued at up to $5,000,000 (effective 2025-12-05).

“On December 5, 2025, CID Holdco, Inc. (the “Company”) entered into a Loan Agreement with J.J. Astor & Co., a Utah corporation (including its successors and assigns, the “Lender”), pursuant to which the Company may borrow up to $5,000,000 in four tranches comprised of an initial $2,000,000 tranche (the “Initial Loan”) borrowed on the initial funding date of December 5, 2025 (the “Initial Funding Date”) and up to three additional tranches of $1,000,000 each (the “Additional Loans” and together with the Initial Loan, the “Loans”).”

Artius II Acquisition Inc. entered into Working Capital Promissory Note with Artius II Acquisition Partners LLC valued at $1,000,000.00 (effective 2026-03-06).

“On March 6, 2026, Artius II Acquisition Inc. (the “Company”) issued a convertible unsecured promissory note (the “Working Capital Promissory Note”) in the aggregate principal amount of up to $1,000,000.00 to Artius II Acquisition Partners LLC”

Cheniere Energy, Inc. entered into Purchase Agreement with Goldman Sachs & Co. LLC, as representative of the initial purchasers named therein valued at $1 billion aggregate principal amount of its 5.200% Senior Notes due 2036 and $750 million aggregate (effective 2026-03-05).

“On March 5, 2026, Cheniere Energy, Inc. (“Cheniere”) entered into a Purchase Agreement (the “Purchase Agreement”) with Goldman Sachs & Co. LLC, as representative of the initial purchasers named therein (the “Initial Purchasers”), to issue and sell to the Initial Purchasers $1 billion aggregate principal amount of its 5.200% Senior Notes due 2036 (the “2036 Notes”) and $750 million aggregate principal amount of its 6.000% Senior Notes due 2056 (the “2056 Notes” and, together with the 2036 Notes, the “Notes”).”

NORTECH SYSTEMS INC amended Waiver and Amendment No. 4 with Bank of America, N.A. (effective 2026-02-27).

“On February 27, 2026, Nortech Systems Incorporated (the “Company”) entered into a Waiver and Amendment No. 4 to its Credit Agreement with Bank of America, N.A., dated February 27, 2026 (“Waiver and Amendment”).”